Question

A 27-year-old man attends a first-seizure clinic after one witnessed generalised convulsive episode. He has recovered fully and has had no previous similar events. Which factor would be least useful when deciding whether to start long-term antiseizure medication after this first seizure?

A. MRI brain shows a focal structural lesion
B. Examination reveals a persistent neurological abnormality
C. EEG demonstrates definite epileptiform discharges
D. The patient is younger than 45 years
E. The patient feels that the risk of another seizure is personally unacceptable

Answer

D. The patient is younger than 45 years

Detailed explanation

After a first unprovoked seizure, antiseizure medication is not started automatically in every patient. The key question is: “Is the risk of recurrence high enough, or unacceptable enough, to justify treatment now?”

NICE advises considering antiseizure medication after a first unprovoked seizure if any of the following are present: neurological deficit, unequivocal epileptic activity on EEG, structural abnormality on brain imaging, or if the person/family/carers consider the risk of another seizure unacceptable after discussion. Age below 45 years is not one of these major criteria. NICE NG217 states this directly in its section on when to start antiseizure medication. NICE NG217

The usual exam principle is: treat after the second unprovoked seizure, but consider treatment after the first if recurrence risk is high or the consequences of recurrence are unacceptable.

Why the other options are wrong

A. MRI brain shows a focal structural lesion
This is relevant. A structural lesion such as cortical scarring, tumour, previous stroke, malformation, or traumatic brain injury increases the likelihood that the first seizure was not an isolated event. Structural brain abnormality is specifically listed by NICE as a reason to consider starting treatment after one seizure.

B. Examination reveals a persistent neurological abnormality
This is relevant. A persistent neurological deficit suggests underlying brain pathology and therefore a higher risk of further seizures. For example, a focal weakness, visual field defect, or other objective neurological sign may point to a structural cortical problem.

C. EEG demonstrates definite epileptiform discharges
This is highly relevant. Definite epileptiform activity on EEG increases the probability of seizure recurrence and supports a diagnosis of epilepsy. The key word is definite or unequivocal; nonspecific EEG abnormalities alone should not be overinterpreted.

D. The patient is younger than 45 years
This is the least relevant factor. Age alone, particularly being under 45, is not a NICE criterion for starting antiseizure medication after a first seizure. Older age may influence the search for causes such as stroke, tumour, alcohol, metabolic disturbance, or syncope mimics, but “less than 45 years old” is not a treatment-starting criterion.

E. The patient feels that the risk of another seizure is personally unacceptable
This is relevant. Patient preference matters because recurrence may have serious consequences: driving restrictions, occupational risk, caring responsibilities, swimming, working at height, operating machinery, or fear of injury. NICE specifically includes this as a reason to consider treatment after discussion.

Key exam point

After a first unprovoked seizure, do not routinely start antiseizure medication. Consider starting it if there is neurological deficit, structural brain abnormality, definite epileptiform EEG activity, or unacceptable recurrence risk to the patient/family/carers.

Very important clinical trap

Do not confuse “first seizure” with “epilepsy confirmed.” Epilepsy is usually diagnosed after recurrent unprovoked seizures, but it may be diagnosed after one unprovoked seizure if recurrence risk is sufficiently high. Also, do not start treatment just because the patient is young. Age below 45 is not a recurrence-risk criterion.

Cheat sheet for exam

• First seizure: urgent specialist assessment, usually within 2 weeks.
• Do not automatically start antiseizure medication after one unprovoked seizure.
• Usually start antiseizure medication after a second epileptic seizure.
• Consider treatment after first unprovoked seizure if:
• Neurological deficit on examination.
• Structural abnormality on brain imaging.
• EEG shows unequivocal epileptic activity.
• Patient/family/carers consider recurrence risk unacceptable.
• Young age alone is not an indication.
• EEG must be interpreted carefully; nonspecific abnormalities are not the same as epileptiform activity.
• Imaging abnormality matters because it suggests a persistent epileptogenic substrate.
• Patient preference is important when another seizure would seriously affect driving, employment, safety, or quality of life.
• Current terminology increasingly uses “antiseizure medication” rather than “antiepileptic drug.”
• Valproate should be avoided as first-start treatment in people under 55 unless strict specialist criteria are met.
• First-line options often include lamotrigine or levetiracetam, depending on seizure type and patient factors.

Flash cards

Q: After a first unprovoked seizure, are antiseizure medications started routinely?
A: No. They are usually started after a second seizure, unless recurrence risk is high or unacceptable.

Q: What EEG finding supports starting treatment after a first seizure?
A: Unequivocal epileptiform activity. Nonspecific slowing or uncertain abnormalities are not enough.

Q: What brain imaging finding supports early treatment?
A: A structural abnormality, such as tumour, cortical scar, previous stroke, malformation, or traumatic lesion.

Q: Why does neurological deficit matter after a first seizure?
A: It suggests underlying brain pathology and therefore higher recurrence risk.

Q: Is being younger than 45 years an indication to start antiseizure medication after one seizure?
A: No. Age below 45 is not a recognised criterion.

Q: Why can patient preference justify treatment after a first seizure?
A: Because another seizure may be unacceptable due to driving, employment, safety, caring duties, or personal risk tolerance.

Q: When is epilepsy usually treated without waiting after the first seizure?
A: When the first seizure occurs in a context suggesting high recurrence risk, such as epileptiform EEG or structural brain abnormality.

Q: Which term is preferred now: antiepileptic drug or antiseizure medication?
A: Antiseizure medication is increasingly preferred because the drug suppresses seizures rather than necessarily curing epilepsy.

MCQs

1. A 31-year-old woman has a single unprovoked generalised tonic-clonic seizure. MRI brain is normal, neurological examination is normal, and EEG is normal. She is not especially worried about recurrence after counselling. What is the best general approach?

A. Start antiseizure medication immediately
B. Reassure and discharge without specialist follow-up
C. Do not routinely start antiseizure medication at this stage
D. Start sodium valproate because it is broad-spectrum
E. Start carbamazepine because it covers all seizure types

Answer: C. Do not routinely start antiseizure medication at this stage.
Explanation: After a first unprovoked seizure, treatment is not automatic. In the absence of neurological deficit, structural abnormality, definite epileptiform EEG changes, or unacceptable recurrence risk, medication is usually deferred while the patient is counselled and followed up.

2. Which of the following is a recognised reason to consider antiseizure medication after a first unprovoked seizure?

A. Patient is under 45 years old
B. Patient is male
C. EEG shows unequivocal epileptic activity
D. Seizure occurred during a stressful week
E. Patient has no family history of epilepsy

Answer: C. EEG shows unequivocal epileptic activity.
Explanation: Definite epileptiform EEG activity indicates increased recurrence risk. Age under 45, sex, stress alone, and absence of family history are not NICE criteria for starting treatment after one seizure.

3. Which of the following is false regarding treatment after a first unprovoked seizure?

A. A structural brain lesion increases recurrence risk
B. A neurological deficit is relevant to treatment decisions
C. Patient preference may influence the decision
D. Being younger than 45 years is a major indication for treatment
E. Definite epileptiform EEG activity supports early treatment

Answer: D. Being younger than 45 years is a major indication for treatment.
Explanation: This is false. Young age alone is not a treatment-starting criterion. The important factors are recurrence-risk markers and patient-centred consequences of recurrence.

4. A 52-year-old lorry driver has a first unprovoked seizure. MRI and examination are normal, but after counselling he feels even a small recurrence risk is unacceptable because of major occupational consequences. Which statement is most accurate?

A. Patient preference is irrelevant because only EEG and MRI matter
B. Treatment can be considered after shared decision-making
C. Treatment is forbidden until a second seizure occurs
D. Treatment should be based only on age
E. Carbamazepine must be started regardless of seizure type

Answer: B. Treatment can be considered after shared decision-making.
Explanation: If the person considers the risk of another seizure unacceptable after discussion, NICE supports considering treatment even after the first unprovoked seizure. This is especially relevant where recurrence has major safety or occupational consequences.

5. A patient has a first seizure and an EEG report showing “mild nonspecific slowing, no epileptiform discharges.” Which interpretation is best?

A. This is equivalent to unequivocal epileptic activity
B. This finding alone mandates treatment
C. It is not the same as definite epileptiform activity
D. It proves the seizure was psychogenic
E. It excludes future epilepsy completely

Answer: C. It is not the same as definite epileptiform activity.
Explanation: The exam wording matters. NICE refers to unequivocal epileptic activity. Nonspecific slowing may reflect many things and should not be treated as diagnostic epileptiform activity.

6. Which of the following is false about structural abnormalities after a first seizure?

A. They may indicate a persistent epileptogenic focus
B. They increase the likelihood of recurrence
C. They are irrelevant if the patient is young
D. They can support starting antiseizure medication after one seizure
E. They include lesions such as previous cortical injury or tumour

Answer: C. They are irrelevant if the patient is young.
Explanation: This is false. Structural abnormalities are relevant at any age because they may represent an ongoing substrate for recurrent seizures.

7. A 23-year-old man has a first unprovoked seizure. Neurological examination shows persistent right upper limb weakness. What is the significance?

A. It lowers recurrence risk
B. It suggests possible underlying brain pathology and is relevant to treatment decisions
C. It is only relevant if he is over 45
D. It proves the seizure was provoked
E. It excludes epilepsy

Answer: B. It suggests possible underlying brain pathology and is relevant to treatment decisions.
Explanation: A neurological deficit is one of the key factors supporting consideration of antiseizure medication after a first unprovoked seizure. It should also prompt careful investigation for structural causes.

Summary for quick exam revision

After a first unprovoked seizure, antiseizure medication is not started automatically. The usual exam rule is to start treatment after a second epileptic seizure, because recurrence confirms a more sustained tendency to seizures. However, treatment can be considered after the first seizure if recurrence risk is high or if another seizure would be personally unacceptable. The major NICE factors are neurological deficit, structural abnormality on brain imaging, unequivocal epileptic activity on EEG, and unacceptable recurrence risk after discussion with the patient, family, or carers. Brain imaging abnormalities matter because they may represent a persistent epileptogenic lesion such as tumour, cortical scarring, stroke, malformation, or previous injury. Neurological deficit matters because it suggests underlying brain dysfunction. EEG is useful only when it shows definite epileptiform activity; vague or nonspecific abnormalities should not be overcalled. Patient preference is not a soft extra point; it is a formal part of shared decision-making because recurrence may affect driving, employment, injury risk, and quality of life. Being younger than 45 years is not an indication to start antiseizure medication after a single seizure. Older age may influence the differential diagnosis and investigation strategy, but age below 45 is not a treatment criterion. The clinical trap is to treat every first seizure as epilepsy requiring lifelong medication. The better approach is to decide whether this was provoked or unprovoked, assess recurrence risk, look for EEG or imaging evidence, examine for neurological deficit, and involve the patient in the risk-benefit decision.